Further identifying proteins that help develop and destroy cardiac muscle cells is a central mission for the Cardiovascular Initiative. By examining the roles specific molecules have in normal and abnormal heart activity they will be able to better understand the many diseases that ultimately lead to heart failure. Boston Biomedical’s Cardiovascular Initiative’s discoveries are certain to produce better treatments for heart disease heart attacks and hypertension than are available today.

Lynne Coluccio, PhD SENIOR SCIENTIST
Janice Dominov, PhD SCIENTIST
Peter Erhardt, MD, PhD SCIENTIST
Jim Fessenden, PhD RESEARCH SCIENTIST
John Gergely, MD, PhD, DScM (HON) SENIOR SCIENTIST
Zenon Grabarek, PhD PRINCIPAL SCIENTIST
Phil Graceffa, PhD SENIOR SCIENTIST
Noriaki Ikemoto, PhD SENIOR SCIENTIST
Toshio Kitazawa, PhD SENIOR SCIENTIST
Sam Lehrer, PhD SENIOR SCIENTIST
Renne Lu, PhD SENIOR SCIENTIST
Eddie Mabuchi, PhD SENIOR RESEARCH ASSOCIATE
Jeff Miller, PhD SENIOR SCIENTIST
Walter Stafford, PhD SENIOR SCIENTIST
Shin Takayama, MD, PhD PRINCIPAL SCIENTIST
Terry Tao, PhD SENIOR SCIENTIST
Albert Wang, PhD SENIOR SCIENTIST
Sarah Wilcox-Adelman, PhD RESEARCH SCIENTIST
Hartmut Wohlrab, PhD SENIOR SCIENTIST